Congress extends diabetes research funding for Type 1 patients and Native Americans
S. 2211 — Special Diabetes Program Reauthorization Act of 2025 · Filed by Susan Collins (R-ME) · 34 cosponsors · Introduced Jul 8, 2025 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill extends federal funding for two existing diabetes research and treatment programs: the Special Diabetes Program for Type 1 Diabetes and the Special Diabetes Program for Indians. It authorizes $160 million annually for fiscal years 2026–2027 for each program, plus an additional $40 million for the final quarter of 2027 (October–December), allowing the programs to continue their work on prevention, treatment, and management of diabetes in these populations.
Why we flagged it
The bill is a straightforward reauthorization and funding extension for two established federal diabetes programs. It contains no policy changes, no new restrictions, and no private carve-outs—only appropriations authority to continue existing services.
Who it affects
The bill extends funding for established public-health programs serving people with Type 1 diabetes and Native American communities, enabling continued research, treatment, and prevention services. No restrictions on citizen rights or remedies are imposed; the mechanism is straightforward appropriation to support existing federal health infrastructure.